Vascular smooth muscle cells (VSMC) are the principal cellular component of
the blood vessel wall where they exist in a differentiated state to mainta
in vascular tone. However, VSMC are not terminally differentiated and can b
e induced to dediffentiate, proliferate, and migrate. In fact, smooth muscl
e cell migration from the vascular wall into the lumen of the vessel is a c
entral feature of occlusive vascular pathologies including atherosclerosis
and intimal hyperplasia. In vitro, in the presence of an extracellular matr
ix, cultured vascular smooth muscle cells can migrate and invade the underl
ying gelatinous matrix, form multicellular nodular aggregations, and secret
e the glycoprotein clusterin. Nodular cultures appear to mimic some of the
properties of differentiated VSMC, in vivo. Here, to test the hypothesis th
at clusterin functions to modulate the formation of VSMC nodules and to fac
ilitate cell migration a clusterin negative VSMC clone, SM-CLU13AS (Moulson
and Millis, 1999, J Cell Physiol 180:355), was transiently transfected wit
h plasmid pRcCMVCLU that contains the full-length porcine clusterin cDNA se
quence under control of the CMV promoter The transiently transfected VSMC c
ulture expressed and secreted clusterin and formed nodules. To determine if
clusterin regulates VSMC migration we used modified Boyden chamber assays.
Clusterin, at 10 mug/ml, clearly promotes VSMC migration. In addition, a 1
5 amino acid synthetic peptide, representing aminoacids 118-132 [KQTCMKFYA-
RVCRSG] of the mature clusterin polypeptide, inhibits VSMC attachment to ge
latinous substrate. Finally, clusterin appears to have a role in regulating
endogenous clusterin expression in the clusterin negative clone. These res
ults clearly establish that clusterin has functional role in VSMC nodule fo
rmation and support the conclusion that clusterin is a critical component o
f smooth muscle eel I phenotypic modulation, J. Cell. Physiol. 186:210-279,
2001. (C) 2001 Wiley-Liss, Inc.